ARCHIVES

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | March 23, 2007

Download PDF Visit The Full Archive

Related Articles

Blazing the Pathways: Informatics Platform Provides Foundation for “Center Without Walls”

January 11, 2013

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002